Pulmonx Corp
(LUNG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 14,767 | 4,124 | N/A | N/A |
| Marketable Securities | 13,580 | N/A | N/A | N/A |
| Receivables | 5,511 | 2,950 | N/A | N/A |
| Inventories | 5,612 | 3,320 | N/A | N/A |
| TOTAL | $41,071 | $11,308 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 902 | 375 | N/A | N/A |
| Intangibles | 2,857 | 2,980 | 0 | 0 |
| Other Non-Current Assets | 8,703 | 350 | 0 | 0 |
| TOTAL | $12,462 | $3,705 | $N/A | $N/A |
| Total Assets | $53,533 | $15,013 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,681 | 1,289 | 0 | 0 |
| Accrued Expenses | 9,463 | 5,876 | N/A | N/A |
| Other current liabilities | 1,165 | 642 | N/A | N/A |
| TOTAL | $14,161 | $8,072 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 14,965 | 14,937 | N/A | N/A |
| Deferred Revenues | 173 | 217 | N/A | N/A |
| Other Non-Current Liabilities | 6,403 | 18,680 | 0 | 0 |
| TOTAL | $21,411 | $33,732 | $N/A | $N/A |
| Total Liabilities | $35,572 | $41,804 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 2 | 2 | N/A | N/A |
| Retained earnings | -210,503 | -189,800 | N/A | N/A |
| Other shareholders' equity | 206,712 | 141,868 | 0 | 0 |
| TOTAL | $17,961 | $-26,791 | $N/A | $N/A |
| Total Liabilities And Equity | $53,533 | $15,013 | $0 | $0 |